Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.

European Journal of Immunology
Margaret A PottsMarco J Herold

Abstract

The mutational landscape of human cancers is highly complex. While next generation sequencing aims to comprehensively catalogue somatic alterations in tumor cells, it fails to delineate driver from passenger mutations. Functional genomic approaches, particularly CRISPR/Cas9, enable both gene discovery, and annotation of gene function. Indeed, recent CRISPR/Cas9 technologies have flourished with the development of more sophisticated and versatile platforms capable of gene knockouts to high throughput genome wide editing of a single nucleotide base. With new platforms constantly emerging, it can be challenging to navigate what CRISPR tools are available and how they can be effectively applied to understand cancer biology. This review provides an overview of current and emerging CRISPR technologies and their power to model cancer and identify novel treatments. Specifically, how CRISPR screening approaches have been exploited to enhance immunotherapies through the identification of tumor intrinsic and extrinsic mechanisms to escape immune recognition will be discussed.

References

Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsuyoshi TachibanaMasayuki Imamura
Mar 9, 2007·Nature·Christopher GreenmanMichael R Stratton
Jun 25, 2010·Nature Reviews. Cancer·Joerg HeyerLynda Chin
Mar 16, 2012·Nature Reviews. Cancer·Wolf Herman FridmanJérôme Galon
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 30, 2013·Methods in Molecular Biology·Wanglong Qiu, Gloria H Su
Sep 28, 2013·Nature Genetics·UNKNOWN Cancer Genome Atlas Research NetworkJoshua M Stuart
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Jul 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·KiBem KimShibin Zhou
Aug 26, 2014·Nature Reviews. Molecular Cell Biology·Stephanie E MohrNorbert Perrimon
Sep 30, 2014·Cell·Randall J PlattFeng Zhang
Oct 14, 2014·Cell·Luke A GilbertJonathan S Weissman
Oct 23, 2014·Nature·Francisco J Sánchez-RiveraTyler Jacks
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Mar 3, 2015·Nature Methods·Alejandro ChavezGeorge M Church
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
May 12, 2015·Nature Biotechnology·Junwei ShiChristopher R Vakoc
May 23, 2015·Molecular Cell·Michael Boettcher, Michael T McManus
Jun 5, 2015·Nature Reviews. Cancer·Francisco J Sánchez-Rivera, Tyler Jacks
Sep 2, 2015·The Journal of Clinical Investigation·Yiping Yang
Nov 18, 2015·Molecular Therapy. Nucleic Acids·Xiao-Hui ZhangShi-Hua Yang
Jan 23, 2016·Current Opinion in Immunology·Federico GarridoThorbald van Hall
May 24, 2016·Nature Immunology·Rebecca B DelconteNicholas D Huntington
Jun 22, 2016·Proceedings of the National Academy of Sciences of the United States of America·Christian J BraunMichael T Hemann
Jul 20, 2016·The New England Journal of Medicine·Jesse M ZaretskyAntoni Ribas
Jul 30, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott Gettinger, Katerina Politi
Nov 5, 2016·The Journal of Experimental Medicine·Brooke A NapierDenise M Monack
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Van Trung ChuKlaus Rajewsky
Nov 1, 2016·Nature Methods·Gaelen T HessMichael C Bassik
Dec 6, 2016·Nature Biotechnology·Bernd ZetscheFeng Zhang

❮ Previous
Next ❯

Citations

Apr 4, 2021·Cancers·Laia Castells-RocaJordi Surrallés
Jul 1, 2021·Clinical & Translational Immunology·Lukman O AfolabiXiaochun Wan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.